Tc. Friedman et al., CARBOHYDRATE AND LIPID-METABOLISM IN ENDOGENOUS HYPERCORTISOLISM - SHARED FEATURES WITH METABOLIC SYNDROME-X AND NIDDM, Endocrine journal, 43(6), 1996, pp. 645-655
Carbohydrate and lipid metabolism was cross-sectionally assessed in 16
patients with endogenous hypercortisolism (endogenous Gushing syndrom
e). Five patients (31%) had fasting glucose levels over 6.6 mmol/l and
a HbA1c over 7.5%. Six patients (38%) had diabetes mellitus based on
an abnormal 75 g oral glucose tolerance test (OGTT) and two additional
patients (13%) had impaired glucose tolerance based on an OGTT. Compa
red to obese individuals, patients with Gushing syndrome had an elevat
ed glucose but no elevated insulin response to the OGTT. Regression an
alysis showed positive correlations between 24-h urinary free cortisol
(UFC) and fasting blood glucose (P<0.0005), UFC and OGTT glucose area
under the curve (AUC) (P<0.01), and UFC and HbA1c (P<0.005). UFC leve
ls were negatively correlated (P<0.05) with OGTT insulin AUC and insul
in/glucose ratios. Eleven (69%) patients required anti-hypertensive th
erapy for blood pressure control. Total cholesterol and triglycerides
were elevated in patients with Gushing syndrome compared to obese cont
rols, while LDL and HDL cholesterol, and Lp(a) were similar in the two
groups. We conclude that impaired glucose tolerance and/or diabetes i
n patients with endogenous Gushing syndrome is due to the hyperglycemi
c effects of cortisol with relative insulinopenia. Thus, Gushing syndr
ome shares features with both the Metabolic Syndrome X and NIDDM, incl
uding impaired glucose uptake, hyperlipidemia and hypertension. Howeve
r, in Gushing syndrome, a relative insulinopenia occurs, while in Meta
bolic Syndrome X and NIDDM, insulin excess is observed. In Gushing syn
drome, as the hypercortisolemia exacerbates, insulinopenia becomes mor
e paramount, suggesting that cortisol exerts a direct or indirect ''to
xic'' effect on the beta-cell.